🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.599.203

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER
Dividend yield
2,83% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 2 días
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
22/11/2022 0,1200 USD
23/08/2022 0,1200 USD
23/05/2022 0,1200 USD
23/02/2022 0,1200 USD
22/11/2021 0,1100 USD
23/08/2021 0,1100 USD
21/05/2021 0,1100 USD
27/06/2007 0,0600 USD
28/03/2007 0,0600 USD
27/12/2006 0,0600 USD
27/09/2006 0,0600 USD
28/06/2006 0,0600 USD
29/03/2006 0,0600 USD
28/12/2005 0,0600 USD
28/09/2005 0,0600 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/05/2020 17,18 17,54 17,11 17,32 +2,73% 2,50% 8.201.600
06/05/2020 16,66 17,18 16,56 16,86 +1,75% 3,72% 7.219.900
05/05/2020 16,60 17,11 16,53 16,57 +0,30% 3,49% 7.236.800
04/05/2020 16,11 16,56 15,74 16,52 +2,42% 5,09% 6.109.100
01/05/2020 16,66 16,67 15,88 16,13 -3,82% 4,74% 3.686.900
30/04/2020 17,10 17,25 16,59 16,77 -3,18% 3,86% 5.824.100
29/04/2020 16,70 17,54 16,56 17,32 +5,35% 5,87% 5.509.500
28/04/2020 16,49 16,90 16,24 16,44 +1,86% 4,00% 7.026.300
27/04/2020 15,87 16,25 15,78 16,14 +2,41% 2,96% 5.336.900
24/04/2020 15,41 15,78 15,30 15,76 +3,01% 3,11% 3.711.500
23/04/2020 15,12 15,58 15,06 15,30 +2,62% 3,44% 3.913.100
22/04/2020 15,33 15,42 14,78 14,91 -1,45% 4,17% 5.530.400
21/04/2020 15,65 15,73 15,11 15,13 -4,60% 3,96% 4.235.500
20/04/2020 16,14 16,25 15,52 15,86 -1,55% 4,52% 4.269.800
17/04/2020 15,90 16,18 15,56 16,11 +3,94% 3,90% 6.430.500
16/04/2020 15,54 15,66 14,79 15,50 +0,26% 5,60% 6.746.100
15/04/2020 15,76 15,85 15,13 15,46 -5,44% 4,57% 4.773.200
14/04/2020 16,30 16,49 16,05 16,35 +1,81% 2,70% 4.936.300
13/04/2020 16,23 16,24 15,55 16,06 -0,12% 4,25% 3.914.400
09/04/2020 15,45 16,54 15,45 16,08 +6,21% 7,06% 9.792.000
08/04/2020 14,57 15,26 14,45 15,14 +5,36% 5,56% 5.861.300
07/04/2020 14,38 15,10 14,04 14,37 +2,35% 7,37% 8.622.700
06/04/2020 14,14 14,65 13,76 14,04 +2,18% 6,29% 9.635.500
03/04/2020 13,85 14,36 13,68 13,74 -1,29% 4,91% 8.137.100
02/04/2020 14,11 14,52 13,60 13,92 -2,38% 6,52% 7.659.400
01/04/2020 14,59 14,87 14,03 14,26 -4,36% 5,76% 6.768.100
31/03/2020 15,07 15,80 14,84 14,91 -1,06% 6,37% 7.529.800
30/03/2020 15,21 15,38 14,43 15,07 +1,28% 6,25% 6.234.300
27/03/2020 15,17 15,39 14,28 14,88 -4,25% 7,32% 6.297.700
26/03/2020 14,88 16,20 14,88 15,54 +4,09% 8,87% 6.579.700